166 related articles for article (PubMed ID: 7920888)
21. Prolonged effect of troglitazone (CS-045) on xenograft survival of hybrid artificial pancreas.
Kawakami Y; Inoue K; Tun T; Hayashi H; Setoyama H; Gu YJ; Cui WX; Imamura M; Iwata H; Ikada Y
Cell Transplant; 1997; 6(5):547-50. PubMed ID: 9331511
[TBL] [Abstract][Full Text] [Related]
22. Thiazolidinediones--the new insulin enhancers.
Jha RJ
Clin Exp Hypertens; 1999; 21(1-2):157-66. PubMed ID: 10052651
[TBL] [Abstract][Full Text] [Related]
23. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects.
Suter SL; Nolan JJ; Wallace P; Gumbiner B; Olefsky JM
Diabetes Care; 1992 Feb; 15(2):193-203. PubMed ID: 1547676
[TBL] [Abstract][Full Text] [Related]
24. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
Sugiyama Y; Shimura Y; Ikeda H
Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
[TBL] [Abstract][Full Text] [Related]
25. Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat.
Yamashita H; Nagai Y; Takamura T; Nohara E; Kobayashi K
Metabolism; 2002 Apr; 51(4):403-8. PubMed ID: 11912544
[TBL] [Abstract][Full Text] [Related]
26. Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes.
Mimura K; Umeda F; Hiramatsu S; Taniguchi S; Ono Y; Nakashima N; Kobayashi K; Masakado M; Sako Y; Nawata H
Diabet Med; 1994; 11(7):685-91. PubMed ID: 7955995
[TBL] [Abstract][Full Text] [Related]
27. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
Maggs DG; Buchanan TA; Burant CF; Cline G; Gumbiner B; Hsueh WA; Inzucchi S; Kelley D; Nolan J; Olefsky JM; Polonsky KS; Silver D; Valiquett TR; Shulman GI
Ann Intern Med; 1998 Feb; 128(3):176-85. PubMed ID: 9454525
[TBL] [Abstract][Full Text] [Related]
28. Troglitazone and related compounds: therapeutic potential beyond diabetes.
Fujiwara T; Horikoshi H
Life Sci; 2000 Oct; 67(20):2405-16. PubMed ID: 11065164
[TBL] [Abstract][Full Text] [Related]
29. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
Plosker GL; Faulds D
Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
Chen S; Noguchi Y; Izumida T; Tatebe J; Katayama S
J Hypertens; 1996 Nov; 14(11):1325-30. PubMed ID: 8934361
[TBL] [Abstract][Full Text] [Related]
31. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
Hevener AL; Reichart D; Janez A; Olefsky J
Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
[TBL] [Abstract][Full Text] [Related]
32. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
Dea MK; Van Citters GW; Ader M; Mittelman SD; Sunehag AL; Bergman RN
Diabetes; 2000 Dec; 49(12):2087-93. PubMed ID: 11118011
[TBL] [Abstract][Full Text] [Related]
33. Acute effects of troglitazone on in vivo insulin action in normal rats.
Lee MK; Olefsky JM
Metabolism; 1995 Sep; 44(9):1166-9. PubMed ID: 7666790
[TBL] [Abstract][Full Text] [Related]
34. The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs.
Matsuhisa M; Shi ZQ; Wan C; Lekas M; Rodgers CD; Giacca A; Kawamori R; Vranic M
Diabetes; 1997 Feb; 46(2):224-31. PubMed ID: 9000698
[TBL] [Abstract][Full Text] [Related]
35. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
[TBL] [Abstract][Full Text] [Related]
36. Lack of effect of CS-045, a new antidiabetic agent, on insulin secretion in the remnant pancreas after 90% pancreatectomy in rats.
Inoue Y; Tanigawa K; Nakamura S; Xu G; Kawaguchi M; Kato Y; Tamura K
Diabetes Res Clin Pract; 1995 Jan; 27(1):19-26. PubMed ID: 7781490
[TBL] [Abstract][Full Text] [Related]
37. Effect of troglitazone on blood insulin levels after pancreas transplantation with systemic venous drainage in rats.
Uchiyama K; Nakai I; Shimizu Y; Mitsuo M; Yasunami Y; Oka T
Transplantation; 1997 Nov; 64(10):1476-8. PubMed ID: 9392315
[TBL] [Abstract][Full Text] [Related]
38. [Troglitazone].
Yamanouchi T
Nihon Rinsho; 2000 Feb; 58(2):389-94. PubMed ID: 10707563
[TBL] [Abstract][Full Text] [Related]
39. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
Chicco A; Basabe JC; Karabatas L; Ferraris N; Fortino A; Lombardo YB
Metabolism; 2000 Oct; 49(10):1346-51. PubMed ID: 11079827
[TBL] [Abstract][Full Text] [Related]
40. Increased insulin responsiveness after CS-045 treatment in diabetes associated with Werner's syndrome.
Takino H; Okuno S; Uotani S; Yano M; Matsumoto K; Kawasaki E; Takao Y; Yamasaki H; Yamaguchi Y; Akazawa S
Diabetes Res Clin Pract; 1994 Jul; 24(3):167-72. PubMed ID: 7988348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
